GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment
British pharmaceutical company GlaxoSmithKline PLC’s (NYSE: GSK) majority-owned subsidiary ViiV Healthcare received the marketing authorization approval for
